Crossmark Global Holdings, Inc. Jazz Pharmaceuticals PLC Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 5,083 shares of JAZZ stock, worth $597,709. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,083

Previous 4,113 23.58%

Holding current value

$597,709

Previous $439,000 29.16%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.57 - $116.37 $97,552 - $112,878	970 Added 23.58%	5,083 $567,000
Q2 2024 Jul 29, 2024	SELL	$103.94 - $118.98 $104,875 - $120,050	-1,009 Reduced 19.7%	4,113 $439,000
Q1 2024 May 13, 2024	SELL	$115.19 - $132.77 $4,837 - $5,576	-42 Reduced 0.81%	5,122 $617,000
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $89,922 - $107,032	-787 Reduced 13.22%	5,164 $636,000
Q3 2023 Nov 08, 2023	SELL	$122.0 - $145.31 $556,564 - $662,904	-4,562 Reduced 43.39%	5,951 $775,000
Q2 2023 Jul 31, 2023	SELL	$122.5 - $147.16 $9,065 - $10,889	-74 Reduced 0.7%	10,513 $1.38 Million
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $477,370 - $571,754	3,563 Added 50.73%	10,587 $1.55 Million
Q4 2022 Jan 19, 2023	BUY	$129.72 - $159.85 $144,637 - $178,232	1,115 Added 18.87%	7,024 $1.12 Million
Q3 2022 Nov 01, 2022	BUY	$126.59 - $161.18 $6,329 - $8,059	50 Added 0.85%	5,909 $788,000
Q2 2022 Jul 29, 2022	SELL	$141.59 - $168.66 $8,495 - $10,119	-60 Reduced 1.01%	5,859 $914,000
Q1 2022 May 11, 2022	BUY	$129.64 - $160.7 $31,113 - $38,568	240 Added 4.23%	5,919 $922,000
Q4 2021 Jan 10, 2022	SELL	$119.87 - $145.67 $85,107 - $103,425	-710 Reduced 11.11%	5,679 $724,000
Q3 2021 Oct 21, 2021	BUY	$128.64 - $184.79 $821,880 - $1.18 Million	6,389 New	6,389 $832,000
Q3 2021 Oct 13, 2021	SELL	$128.64 - $184.79 $841,176 - $1.21 Million	-6,539 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$160.2 - $186.42 $47,259 - $54,993	295 Added 4.72%	6,539 $1.16 Million
Q1 2021 Apr 15, 2021	BUY	$150.19 - $173.5 $13,517 - $15,615	90 Added 1.46%	6,244 $1.03 Million
Q4 2020 Jan 14, 2021	BUY	$140.71 - $165.05 $161,816 - $189,807	1,150 Added 22.98%	6,154 $1.02 Million
Q3 2020 Oct 08, 2020	BUY	$105.46 - $144.13 $527,721 - $721,226	5,004 New	5,004 $714,000
Q4 2018 Jan 31, 2019	SELL	$115.94 - $166.74 $302,603 - $435,191	-2,610 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$161.01 - $180.57 $19,321 - $21,668	120 Added 4.82%	2,610 $439,000
Q2 2018 Jul 31, 2018	BUY	$146.33 - $183.18 $364,361 - $456,118	2,490 New	2,490 $429,000

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.37B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Jazz Pharmaceuticals PLC Transaction History